Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2009

Study Completion Date

February 28, 2010

Conditions
Post-stroke Shoulder Pain and Spasticity
Interventions
DRUG

Botulinum Toxin Type A - OnabotulinumtoxinA

100-200 units injected into the pectoralis major. The teres major may also be injected if tone is noted in shoulder extensors.

DRUG

Placebo (Saline)

Equivalent volume of saline without study drug injected into the pectoralis major. Teres major was also injected if tone noted in the shoulder extensors.

Trial Locations (1)

60302

Rehabilitation Institute of Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Shirley Ryan AbilityLab

OTHER

NCT00661089 - Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity | Biotech Hunter | Biotech Hunter